James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Culp Has to Do This to Keep General Electric Stock Moving Higher

The rebound effort General Electric stock was trying to make a few weeks ago petered out. The one that last will likely be built on a more aggressive acquisition strategy.

The Tables Could Soon Turn Back in Favor of Tilray Stock

Tilray stock has been beaten to a pulp, like most other pot stocks. But, there's a nuance here that could readily reignite TLRY shares.

3 Big Stock Charts for Tuesday: AbbVie, S&P Global and FleetCor Technologies

The stock charts of ABBV, FLT and SPGI are knocking on the doors of tradeworthy moves as today's session kicks off.

The Good News and the Bad News for New Age Beverages Stock

New Age Beverages is the real deal, but a disconnect between it and NBEV stock ended up punishing many unsuspecting investors.

Intel Stock Is Being Held Back by Little More Than Fear

INTC admittedly blew the lead it had on rival AMD. But Intel's rebuilding effort is for real, and INTC stock is due for a better valuation.

3 Big Stock Charts for Monday: Amazon, Broadcom and Intercontinental Exchange

The stock charts of AMZN, ICE and AVGO are in position to start the new trading week with a bang. Here's everything you need to know about each.

Going Big on Vaping Is a Serious Headwind for Cronos Stock

Cronos Group was already struggling to turn a profit and gain market share. Now the deterioration of a growth prospect could completely up-end CRON stock.

Tesla’s Production Increase Could Boost TSLA Stock

TSLA stock has been brutalized for the company's failure to reach sustained EV profitability, but TSLA is getting closer every quarter.

3 Big Stock Charts for Friday: Conagra Brands, HollyFrontier and Vertex Pharmaceuticals

The stock charts of CAG, VRTX and HFC are poised to end the trading week in pivotal situations. Here's what you should know about each.

4 Stocks to Sell and 6 Stocks to Buy on Vaping Fears

Turning Point Brands, Cronos Group and Altria are just some of the stocks to buy or sell here at a pivotal time for vaporizers.